A phase I study of the novel, third generation epothilone ZK-EPO in patients with advanced solid tumors.

被引：0
|
作者：
Schmid, P
Kiewe, P
Kuehnhardt, D
Korfel, A
Lindemann, S
Giurescu, M
Reif, S
Thiel, E
Possinger, K
机构：
[1] Humboldt Univ, Berlin, Germany
[2] Schering AG, Berlin, Germany
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2005年 / 23卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：147S / 147S
页数：1
相关论文
共 50 条
  • [31] A phase I clinical and pharmacokinetic study of EPO906 (epothilone B) in patients with advanced solid tumours.
    Calvert, PM
    O'Neill, V
    Azzabi, A
    Hughes, A
    Plummer, R
    Twelves, C
    Robinson, A
    Machan, MA
    Dimitrijevic, S
    Moss, D
    Rothermel, J
    Cohen, P
    Chen, T
    Man, A
    Calvert, AH
    CLINICAL CANCER RESEARCH, 2000, 6 : 4581S - 4581S
  • [32] Phase I study of the pharmacokinetics and tolerability of everolimus in Chinese patients with advanced solid tumors.
    Xu, B.
    Shen, L.
    Ye, D.
    Jappe, A.
    Wang, H.
    Yuan, R.
    Wu, Y.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [33] A phase I study evaluating COM701 in patients with advanced solid tumors.
    Rasco, Drew W.
    Papadopoulos, Kyriakos P.
    Adewoye, Adeboye H.
    Hunter, John
    Ramsey, Denise
    ElNaggar, Adam
    Patnaik, Amita
    Vaena, Daniel A.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (08)
  • [34] A phase I and pharmacokinetic study of PEG-camptothecin in patients with advanced solid tumors.
    Hao, D
    Tolcher, AW
    Rizzo, JD
    Ochoa, L
    McCreery, H
    Schwartz, GH
    Patnaik, A
    Denis, LJ
    Hammond, LA
    Hidalgo, M
    Kwiatek, J
    McGuire, J
    Rowinsky, EK
    CLINICAL CANCER RESEARCH, 2000, 6 : 4513S - 4513S
  • [35] Phase I study of olaparib in combination with carboplatin and/or paclitaxel in patients with advanced solid tumors.
    van der Noll, Ruud
    Ang, Joo Ern
    Jager, Agnes
    Marchetti, Serena
    Mergui-Roelvink, Marja
    De Bono, Johann Sebastian
    Lolkema, Martijn
    Brunetto, Andre
    Arkenau, Hendrik-Tobias
    De Jonge, Maja J.
    van der Biessen, Diane
    Tchakov, Ilian
    Bowen, Karin
    Schellens, Jan H. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [36] A phase I study evaluating COM701 in patients with advanced solid tumors.
    Rasco, Drew W.
    Vaena, Daniel A.
    Sullivan, Ryan J.
    Luke, Jason J.
    ElNaggar, Adam
    Hunter, John
    Adewoye, Adeboye H.
    Olweny, Judy
    Patnaik, Amita
    Hamilton, Erika Paige
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [37] A phase I clinical study of biweekly pemetrexed and gemcitabine in patients with advanced solid tumors.
    Dudek, A
    Larson, T
    Mellskog, CE
    Bloss, LP
    Obasaju, C
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 162S - 162S
  • [38] A phase I study of a novel, trinuclear, platinum analogue, BBR3464, in patients with advanced solid tumors.
    Calvert, PM
    Highley, MS
    Hughes, AN
    Plummer, ER
    Azzabi, AST
    Verrill, MW
    Camboni, MG
    Verdi, E
    Bernareggi, A
    Zucchetti, M
    Robinson, AM
    Carmichael, J
    Calvert, AH
    CLINICAL CANCER RESEARCH, 1999, 5 : 3796S - 3796S
  • [39] Phase I trial of irinotecan and epirubicin in patients with advanced solid tumors.
    Gold, PJ
    Refice, S
    West, H
    JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 164S - 164S
  • [40] A phase I study of carboxyamidotriazole orotate (CTO) in of advanced solid tumors.
    Sandler, Alan
    Taylor, Matthew Hiram
    Urba, Walter John
    Omuro, Antonio Marcilio Padula
    Anderson, Barry Douglas
    Hansen, Daniel
    Fisher, Brenda
    Claeys, Alisa J.
    Greathouse, Amy
    McLean, Sean
    Karmali, Rashida A.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
12345